Matter effects on the flavor conversions of solar neutrinos and high-energy astrophysical neutrinos

Can we observe the solar eclipses in the neutrino light? In principle, this is possible by identifying the lunar matter effects on the flavor conversions of solar neutrinos when they traverse the Moon before reaching the detectors at the Earth. Unfortunately, we show that the lunar matter effects on the survival probability of solar $^8{\rm B}$ neutrinos are suppressed by an additional factor of $1.2\%$, compared to the day-night asymmetry. However, we point out that the matter effects on the flavor conversions of high-energy astrophysical neutrinos, when they propagate through the Sun, can be significant. Though the flavor composition of high-energy neutrinos can be remarkably modified, it is quite challenging to observe such effects even in the next-generation of neutrino telescopes.Comment: 20 pages, 2 figures, accepted by Nuclear Physics

Large shift current via in-gap and charge-neutral exciton excitations in BN nanotubes and single BN layer

We perform {\it ab initio} many-body calculations to investigate the exciton shift current in small diameter zigzag BN nanotubes and also single BN sheet, using the GW plus Bethe-Salpeter equation (GW-BSE) method with the newly developed efficient algorithms. Our GW-BSE calculations reveal a giant in-gap peak in the shift current spectrum in all the studied BN systems due to the excitation of the A exciton. The peak value of the excitonic shift current is more than three times larger than that of the quasiparticle shift current, and is attributed to the gigantic enhancement of the optical dipole matrix element by the A exciton resonance. The effective exciton shift current conductivity is nearly ten times larger than the largest shift conductivity observed in ferroelectric semiconductors. Importantly, the direction of the shift current in the BN nanotubes is found to be independent of the tube chirality ($n,0$) (or diameter), contrary to the simple rule of $sgn(J_\text{shift})=\text{mod}(n,3)$ predicted by previous model Hamiltonian studies. Finally, our {\it ab initio} calculations also show that the exciton excitation energies decrease significantly with the decreasing diameter due to the curvature-induced orbital rehybridization in small diameter zigzag BN nanotubes.Comment: 12 pages, 8 figures and 2 table

Evolution of topological charge through chiral anomaly transport

Built upon the state-of-the-art model a multiphase transport (AMPT), we develop a new module of chiral anomaly transport (CAT), which can trace the evolution of the initial topological charge of gauge field created through sphaleron transition at finite temperature and external magnetic field in heavy ion collisions. The eventual experimental signals of chiral magnetic effect(CME) can be measured. The CAT explicitly shows the generation and evolution of the charge separation, and the signals of CME through the CAT are quantitatively in agreement with the experimental measurements in Au+Au collision at $\sqrt{s}=200 {\rm GeV}$, and the centrality dependence of the CME fraction follows that of the fireball temperature.Comment: 7 pages, 6 figure

SAROTUP: Scanner and Reporter of Target-Unrelated Peptides

As epitope mimics, mimotopes have been widely utilized in the study of epitope prediction and the development of new diagnostics, therapeutics, and vaccines. Screening the random peptide libraries constructed with phage display or any other surface display technologies provides an efficient and convenient approach to acquire mimotopes. However, target-unrelated peptides creep into mimotopes from time to time through binding to contaminants or other components of the screening system. In this study, we present SAROTUP, a free web tool for scanning, reporting and excluding possible target-unrelated peptides from real mimotopes. Preliminary tests show that SAROTUP is efficient and capable of improving the accuracy of mimotope-based epitope mapping. It is also helpful for the development of mimotope-based diagnostics, therapeutics, and vaccines